Status:
ACTIVE_NOT_RECRUITING
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
Lead Sponsor:
Ono Pharmaceutical Co., Ltd.
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Eligibility Criteria
Inclusion Criteria:
- Japanese (both sexes)
- Outpatient
- Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
- Patients who meet the American College of Rheumatology Fibromyalgia Criteria
Exclusion Criteria:
- Patients with inflammatory arthritis, infectious arthritis, or autoimmune disease
- Patients with pain other than FM that may affect assessments in this study
- Patients with a past history of or concurrent neurologic diseases that may affect assessments in this study
- Patients with a past history of or concurrent malignant tumor within 3 years
- Patients who are pregnant, nursing, or possibly pregnant, or intending to become pregnant during the study period.
Key Trial Info
Start Date :
March 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06752590
Start Date
March 26 2025
End Date
September 1 2026
Last Update
March 25 2026
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi Medical University Hospital
Nagakute, Aichi-ken, Japan
2
Kimura Clinic
Nagoya, Aichi-ken, Japan
3
National Hospital Organization Shimoshizu National Hospital
Yotsukaidō, Chiba, Japan
4
Ai Sakura Clinic
Fukuoka, Fukuoka, Japan